arrow_back Back Filing freshness 10-Q FY 2026 SEC EDGAR

Prestige Consumer Healthcare Inc.

PBH
$44.33 ▼ -8.98 (-16.85%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
18 Visible periods
32 Metrics
Peer-ranked Benchmarks
Price Chart
70
Health
Good
Bullish
auto_awesome

Analytical Summary

Prestige Consumer Healthcare Inc. shows strong fundamentals with top-quartile Profit Margin (%) and Operating Margin (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $2.1B
Dividend Yield —
Revenue Growth -4.3% ↘
Op. Margin 28.4% ↘
ROIC 7.9% ↘
FCF / Share $5.09 ↗
Trailing P/E 11.3x
Price / Book 1.1x
FCF Yield 11.5%
Debt / Equity 0.53
info Valuation on last close. End-of-day price, Nov 5, 2026.

18-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$1.09B
↓ -4.3% —
Net Income Profit after all expenses
$190.30M
↓ -11.3% —
Operating Margin Operating profit as % of sales
28.4%
↓ -4.0% 92th
FCF / Share Free cash flow per share
$5.09
↑ +3.9% —
Long-Term Debt Long-term obligations
$993.95M
— +0.2% —
trending_up

Bullish Indicators

  • Operating Margin (%)Operating Margin (%) is in the top quartile
  • Profit Margin (%)Profit Margin (%) is in the top quartile
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Profitability ↓
86
Returns ↓
62
Financial Health →
56
Cash Quality ↑
75

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 18 years · 67 quarters